iShares NASDAQ Biotechnology Index Company Profile (NASDAQ:IBB)

About iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

iShares NASDAQ Biotechnology Index logoiShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund's investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.

Industry, Sector and Symbol:
  • Sector: Finance
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:IBB
  • CUSIP: N/A
  • Web: N/A
Average Prices:
  • 50 Day Moving Avg: $292.20
  • 200 Day Moving Avg: $285.23
  • 52 Week Range: $240.30 - $303.74
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Misc:
  • Average Volume: 1.01 million shs.
  • Beta: 1.32
 

Frequently Asked Questions for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

What is iShares NASDAQ Biotechnology Index's stock symbol?

iShares NASDAQ Biotechnology Index trades on the NASDAQ under the ticker symbol "IBB."

How often does iShares NASDAQ Biotechnology Index pay dividends? What is the dividend yield for iShares NASDAQ Biotechnology Index?

iShares NASDAQ Biotechnology Index declared a quarterly dividend on Friday, March 24th. Stockholders of record on Tuesday, March 28th will be given a dividend of $0.299 per share on Thursday, March 30th. This represents a $1.20 annualized dividend and a dividend yield of 0.41%. The ex-dividend date of this dividend is Friday, March 24th. This is an increase from iShares NASDAQ Biotechnology Index's previous quarterly dividend of $0.09. View iShares NASDAQ Biotechnology Index's Dividend History.

Who are some of iShares NASDAQ Biotechnology Index's key competitors?

Who owns iShares NASDAQ Biotechnology Index stock?

iShares NASDAQ Biotechnology Index's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Morgan Stanley (0.00%), JPMorgan Chase & Co. (0.00%), Alliancebernstein L.P. (0.00%), Clal Insurance Enterprises Holdings Ltd (0.00%), PNC Financial Services Group Inc. (0.00%) and Commerce Bank (0.00%). View Institutional Ownership Trends for iShares NASDAQ Biotechnology Index.

Who sold iShares NASDAQ Biotechnology Index stock? Who is selling iShares NASDAQ Biotechnology Index stock?

iShares NASDAQ Biotechnology Index's stock was sold by a variety of institutional investors in the last quarter, including NF Trinity Capital Hong Kong Ltd, Neuberger Berman Group LLC, Virtu Financial LLC, Nomura Holdings Inc., Clal Insurance Enterprises Holdings Ltd, Janney Montgomery Scott LLC, HighTower Advisors LLC and Eagle Global Advisors LLC. View Insider Buying and Selling for iShares NASDAQ Biotechnology Index.

Who bought iShares NASDAQ Biotechnology Index stock? Who is buying iShares NASDAQ Biotechnology Index stock?

iShares NASDAQ Biotechnology Index's stock was purchased by a variety of institutional investors in the last quarter, including Morgan Stanley, JPMorgan Chase & Co., Alliancebernstein L.P., Lockheed Martin Investment Management Co., Seatown Holdings Pte. Ltd., Two Sigma Securities LLC, Janney Capital Management LLC and Ameriprise Financial Inc.. View Insider Buying and Selling for iShares NASDAQ Biotechnology Index.

How do I buy iShares NASDAQ Biotechnology Index stock?

Shares of iShares NASDAQ Biotechnology Index can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of iShares NASDAQ Biotechnology Index stock cost?

One share of iShares NASDAQ Biotechnology Index stock can currently be purchased for approximately $291.16.

Analyst Ratings

Consensus Ratings for iShares NASDAQ Biotechnology Index (NASDAQ:IBB) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: N/A

Analysts' Ratings History for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
3/21/2017Credit Suisse Group AGUpgradeMarket Weight -> OverweightHighView Rating Details
(Data available from 5/25/2015 forward)

Earnings

Earnings History for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Current Dividend Information for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)
Most Recent Dividend:3/30/2017
Annual Dividend:$0.49
Dividend Yield:0.17%
Payout Ratio:
Dividend Payments by Quarter for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

Dividend History by Quarter for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/24/2017quarterly$0.300.41%3/24/20173/28/20173/30/2017
12/22/2016quarterly$0.090.14%12/22/201612/27/201612/29/2016
6/24/2015quarterly$0.060.06%6/24/20156/26/20156/30/2015
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)
Latest Headlines for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)
Source:
DateHeadline
nasdaq.com logoMid-Day ETF Update: ETFs, Stocks Modestly Higher Ahead of FOMC Statement - Nasdaq
www.nasdaq.com - May 24 at 5:40 PM
investorplace.com logoThe Move in iShares Nasdaq Biotechnology Index (ETF) (IBB) ETF Is Coming — Get on Board
investorplace.com - May 23 at 5:25 PM
finance.yahoo.com logoWinners And Losers From Trump's $4 Trillion Budget Proposal
finance.yahoo.com - May 23 at 5:25 PM
finance.yahoo.com logoWhat To Make Of the Alexion Shake-up
finance.yahoo.com - May 23 at 5:25 PM
americanbankingnews.com logoInvestors Purchase Large Volume of iShares NASDAQ Biotechnology Index Put Options (IBB)
www.americanbankingnews.com - May 23 at 1:22 PM
finance.yahoo.com logoAre Stock Returns during Summer Months That Bad?
finance.yahoo.com - May 19 at 10:19 AM
finance.yahoo.com logoWill Biotech Ever Move Higher?
finance.yahoo.com - May 19 at 10:19 AM
americanbankingnews.com logoiShares NASDAQ Biotechnology Index (IBB) Upgraded by Vetr Inc. to Buy
www.americanbankingnews.com - May 18 at 12:56 AM
finance.yahoo.com logoThe Latest Market Trends Every Biopharma Investor Needs to Know
finance.yahoo.com - May 17 at 10:46 PM
nasdaq.com logoMid-Day ETF Update: ETFs, Stocks Slump as Trump-Related Controversies Stoke Concerns - Nasdaq
www.nasdaq.com - May 17 at 5:45 PM
finance.yahoo.com logoCalm Down, People! Over-Reacting to Equity Markets
finance.yahoo.com - May 17 at 5:45 PM
nasdaq.com logoFore Research & Management, LP Buys SPDR Gold Trust, Syngenta AG, iShares Nasdaq ...
www.nasdaq.com - May 17 at 10:04 AM
investorplace.com logoiShares Nasdaq Biotechnology Index (ETF) (IBB): The Quick Guide to IBB - Investorplace.com
investorplace.com - May 16 at 5:43 PM
investorplace.com logoiShares Nasdaq Biotechnology Index (ETF) (IBB): The Quick Guide to IBB - Investorplace.com
investorplace.com - May 16 at 5:43 PM
nasdaq.com logoETF Preview: ETFs, Futures Point Higher, Shrug Off Trump-Russia News, Housing Data Miss
www.nasdaq.com - May 16 at 11:15 AM
nasdaq.com logoMid-Day ETF Update: ETFs, Stocks Higher as Crude Oil Rally Offsets Worries Over Cyberattacks, North Korean Missile Test
www.nasdaq.com - May 15 at 5:19 PM
nasdaq.com logoETF Preview: ETFs, Futures Mixed as Caution Over Weekend Cyberattacks Offset Crude Rally
www.nasdaq.com - May 15 at 10:58 AM
nasdaq.com logoETF Preview: ETFs, Futures Mixed to Higher on Upbeat Weekly Jobless Claims, PPI Data but Comey Controversy Continues to Weigh
www.nasdaq.com - May 11 at 11:25 PM
finance.yahoo.com logoSenate Needs To Move Fast On Healthcare Before Overhauling Tax Code
finance.yahoo.com - May 11 at 11:25 PM
finance.yahoo.com logoBiotech ETFs Sink After House Passage of Health-Care Bill
finance.yahoo.com - May 11 at 6:23 PM
fool.com logoWhy Gilead Sciences Stock Lagged Behind Other Biotechs in April - Motley Fool
www.fool.com - May 10 at 11:29 PM
americanbankingnews.com logoiShares NASDAQ Biotechnology Index (IBB) Upgraded to "Buy" at Vetr Inc.
www.americanbankingnews.com - May 9 at 12:39 AM
americanbankingnews.com logoiShares NASDAQ Biotechnology Index (IBB) Upgraded at Vetr Inc.
www.americanbankingnews.com - May 9 at 12:18 AM
finance.yahoo.com logoKITE Plunges, Take Sector With It
finance.yahoo.com - May 8 at 5:28 PM
marketwatch.com logoRich Ross Is Bullish On The NASDAQ Biotech ETF
www.marketwatch.com - May 6 at 5:52 PM
barrons.com logoCelgene: Too Much of a Good Thing? - Barron's
www.barrons.com - May 5 at 5:47 PM
nasdaq.com logoMid-Day ETF Update: ETFs, Stocks Mixed As Uncertainty Over French Elections Offsets Strong April Jobs Data - Nasdaq
www.nasdaq.com - May 5 at 5:47 PM
finance.yahoo.com logoHere are two great reasons to buy biotech: Technician
finance.yahoo.com - May 5 at 5:47 PM
finance.yahoo.com logoA Biotech Warning Sign?
finance.yahoo.com - May 4 at 5:57 PM
nasdaq.com logoCompany Spotlight: Conatus Pharma
www.nasdaq.com - May 4 at 11:53 AM
americanbankingnews.com logoStock Traders Buy Large Volume of iShares NASDAQ Biotechnology Index Call Options (IBB)
www.americanbankingnews.com - May 3 at 11:52 AM
nasdaq.com logoMid-Day ETF Update: ETFs, Stocks Hold on to Gains Ahead of FOMC Meeting Conclusion, Apple Results - Nasdaq
www.nasdaq.com - May 2 at 4:17 PM
americanbankingnews.com logoiShares NASDAQ Biotechnology Index (IBB) Earning Very Favorable Media Coverage, Study Shows
www.americanbankingnews.com - May 2 at 2:52 PM
americanbankingnews.com logoiShares NASDAQ Biotechnology Index (IBB) Earning Somewhat Positive Media Coverage, Study Finds
www.americanbankingnews.com - April 29 at 7:44 PM
seekingalpha.com logoSizing Up Biotech Charts
seekingalpha.com - April 28 at 6:49 PM
finance.yahoo.com logoTrump's first 100 days, now what?
finance.yahoo.com - April 28 at 6:49 PM
nasdaq.com logoETF Preview: ETFs, Futures Higher Following Slowdown in Q1 GDP Growth; Chicago PMI, Consumer Sentiment Still Ahead
www.nasdaq.com - April 28 at 10:09 AM
americanbankingnews.com logoiShares NASDAQ Biotechnology Index (IBB) Receives Media Impact Score of 0.17
www.americanbankingnews.com - April 26 at 6:32 PM
nasdaq.com logoMid-Day ETF Update: ETFs, Stocks Maintain Rally as Upbeat Earnings, Tax Reform Expectations Lift Market Sentiment
www.nasdaq.com - April 25 at 5:20 PM
finance.yahoo.com logoBiogen's Excellent Q1 Bodes Well for Biotech
finance.yahoo.com - April 25 at 10:46 AM
finance.yahoo.com logoBiogen: Stuck in a Rut?
finance.yahoo.com - April 25 at 10:46 AM
nasdaq.com logoMid-Day ETF Update: ETFs, Stocks Higher on Relief Rally Following French Elections
www.nasdaq.com - April 24 at 5:32 PM
americanbankingnews.com logoiShares NASDAQ Biotechnology Index (IBB) Raised to "Buy" at Vetr Inc.
www.americanbankingnews.com - April 24 at 2:24 PM
seekingalpha.com logoCelgene And Biogen Earnings Could Make Or Break The Biotech Sector - Seeking Alpha
seekingalpha.com - April 24 at 8:32 AM
americanbankingnews.com logoiShares NASDAQ Biotechnology Index (IBB) Earning Favorable News Coverage, Report Shows
www.americanbankingnews.com - April 23 at 6:14 PM
nasdaq.com logoETF Preview: ETFs, Futures Higher on Hopes for Trump's Tax Reform; Markit Flash Data, Existing Home Sales Still Ahead - Nasdaq
www.nasdaq.com - April 21 at 10:50 AM
americanbankingnews.com logoiShares NASDAQ Biotechnology Index (IBB) Earns Daily News Sentiment Rating of 0.39
www.americanbankingnews.com - April 20 at 9:24 PM
nasdaq.com logoETF Preview: ETFs Modestly Higher, Futures Mixed Following Jobless Claims Data; March Leading Indicators Still Ahead
www.nasdaq.com - April 20 at 11:35 AM
americanbankingnews.com logo iShares NASDAQ Biotechnology Index (IBB) Receives Consensus Rating of "" from Analysts
www.americanbankingnews.com - April 19 at 8:11 PM
marketwatch.com logoWhy biotech stocks are a healthy bet in sickly broader market
www.marketwatch.com - April 19 at 5:41 PM

Social

Chart

iShares NASDAQ Biotechnology Index (IBB) Chart for Thursday, May, 25, 2017

This page was last updated on 5/25/2017 by MarketBeat.com Staff